Well providing they have enough approvals in different jurisdictions they will have sufficient access to get multicentre trials done, so what they have is quite important. But trials are expensive and take a long time to do.
Ann: OncoSil TGA regulatory update, page-37
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.62M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $3.119K | 260.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2097842 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 5424100 | 9 |
View Market Depth
| Last trade - 10.56am 03/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |